Subsequently, four overlapping genes, AMDHD1, FMO1, LPL, and P4HA1, were obtained using these algorithms (Fig. 3E) and defined as metabolism-related biomarkers (MRBs) in NAFLD. This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.